Skip to main content
Fig. 1 | Renal Replacement Therapy

Fig. 1

From: Association of serum sodium minus chloride level at initiation of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and hyperkalemia in patients with CKD: a case control study

Fig. 1

Relationship between [HCO3] and [Na+] − [Cl] at the initiation of ACE-I or ARB. A. Scatter plot of [HCO3] and [Na+] − [Cl]. From the linear regression analysis, [Na+] − [Cl] was significantly related with [HCO3] (r = 0.67 and p < 0.001). B. Receiver operating curve analysis for [Na+] − [Cl] for predicting metabolic acidosis ([HCO3] < 24 mEq/L). From this analysis, 33.5 mEq/L had the highest Yoden indices (sensitivity + specificity − 1). Using this cutoff value, the sensitivity and specificity of [Na+] − [Cl] for metabolic acidosis was 75.2% and 75.0%, respectively, while the area under the ROC curve was 0.81 (95% confidential interval 0.78–0.85). [HCO3], serum bicarbonate level; [Na+], serum sodium level; [Cl], serum chloride level; ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker

Back to article page